argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

argenx (Euronext & Nasdaq: ARGX), a global immunology company focused on severe autoimmune diseases, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Tim Van Hauwermeiren, the company's CEO, will deliver a presentation on Monday, January 13, 2025 at 9:45 a.m. PT.

The presentation will be accessible through a live webcast on the Investors section of the argenx website (argenx.com/investors). A replay option will remain available on the company's website for approximately 30 days after the presentation.

January 6, 2025

Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Tim Van Hauwermeiren, Chief Executive Officer, will present at the 43^rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 9:45 a.m. PT.

A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 30 days following the presentation.

About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker, globally in the U.S., Japan, Israel, the EU, the UK, China and Canada. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, X/Twitter, Instagram, Facebook, and YouTube.

For further information, please contact:

Media:

Ben Petok
bpetok@argenx.com

Investors:

Alexandra Roy (US)
aroy@argenx.com

Lynn Elton (EU)
lelton@argenx.com

FAQ

When is argenx (ARGX) presenting at the 2025 J.P. Morgan Healthcare Conference?

argenx will present at the conference on Monday, January 13, 2025, at 9:45 a.m. PT.

How can investors watch argenx's (ARGX) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation via live webcast on the Investors section of argenx's website at argenx.com/investors.

How long will the replay of argenx's (ARGX) J.P. Morgan presentation be available?

The presentation replay will be available on argenx's website for approximately 30 days following the presentation.

Who will represent argenx (ARGX) at the 2025 J.P. Morgan Healthcare Conference?

Tim Van Hauwermeiren, argenx's Chief Executive Officer, will represent the company at the conference.